Older HIV patients in kenya try a simpler two-drug pill
NCT ID NCT06444620
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 27 times
Summary
This study looks at whether switching older adults (60+) with HIV from a three-drug pill (B/F/TAF) to a two-drug pill (DTG/3TC) is safe and keeps the virus under control. About 240 participants in Kenya will take the new pill for 96 weeks. The main goal is to see how many have detectable virus at 48 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV -1 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jaramogi Oginga Odinga Teaching and Referral Hospital
Kisumu, Kenya
-
Kenyatta National Hospital
Nairobi, Kenya
Conditions
Explore the condition pages connected to this study.